Form 4 for NVCR NovoCure Ltd
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001811030-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | NVCR | Weinberg Uri | Chf Medical, Innovation Ofr | A - Grant | $0.00 | +50.1K | 273.6K | +22% | $0 |
| D | 2026-03-05 | 2026-03-04 | NVCR | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale | $13.31 | -6,412 | 267.2K | -2% | -$85.3K |
| D | 2026-03-05 | 2026-03-03 | NVCR | Weinberg Uri | Chf Medical, Innovation Ofr | A - Grant | $0.00 | +73.3K | 73.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-03 | A | A | 50,125 | $0.00 | 273,602 | D | — | — | (F1) Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates. |
| 2 | Common | Ordinary Shares | 2026-03-04 | S | D | 6,412 | $13.31 | 267,190 | D | — | — | (F2) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. (F3) This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | A | A | 73,340 | $0.00 | 73,340 | D | $13.30 · — to 2036-03-03 | 73,340 Ordinary Shares | (F4) Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date. |